Healthcare use after screening for lung cancer

Cancer

Volumn 116, Issue 20, 2010, Pages 4793-4799

  Byrne, Margaret M ^a   Koru Sengul, Tulay ^a   Zhao, Wei ^a   Weissfeld, Joel L ^b   Roberts, Mark S ^c  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Costs; Healthcare use; Lung cancer; Screening; Survey

Indexed keywords

ADULT; AGED; AMBULATORY CARE; ARTICLE; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; FALSE POSITIVE RESULT; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH PERCEPTIONS QUESTIONNAIRE; HEALTH SURVEY; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT CARE; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; TREND STUDY; VISUAL ANALOG SCALE; EARLY DIAGNOSIS; ECONOMICS; LABORATORY DIAGNOSIS; LUNG TUMOR; MASS SCREENING; MIDDLE AGED; PATIENT ATTITUDE; PSYCHOLOGICAL ASPECT; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; STATISTICS;

EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; TOMOGRAPHY, SPIRAL COMPUTED;

EID: 78349273597     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25466     Document Type: Article

References (38)

1. Lerman C, Engstrom PF, Rimer BK. Cancer risk notification: psychosocial and ethical implications. J Clin Oncol. 1991;9:1275-1282.
2. Lerman C, Smith D, Nolte S, Hanjani P, Scarborough R, Miller SM. Adverse psychologic consequences of positive cytologic cervical screening. Am J Obstet Gynecol. 1991;165:658-662.
3. Primic Zakelj M. Screening mammography for early detection of breast cancer. Ann Oncol. 1999;10:6121-6127.
4. Broadstock M, Marteau T, Michie S. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet. 2000;8:731-738.
5. Aktan Collan K, Kaariainen H, Uutela A, Mecklin JP, Haukkala A. Psychological consequences of predictive genetic testing for hereditary non polyposis colorectal cancer (HNPCC): a prospective follow up study. Int J Cancer. 2001;93:608-611. (Pubitemid 32701422)
6. Wiggins S, Hayden MR, Schechter MT, et al. The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med. 1992;327:1401-1405.
7. Ong G, Brett J, Austoker J. Breast screening: adverse psychological consequences one month after placing women on early recall because of a diagnostic uncertainty. A multicentre study. J Med Screen. 1997;4:158-168. (Pubitemid 28270257)
8. Wardle FJ, Campbell S, Whitehead MI, Pernet AL, Collins W. Psychological impact of screening for familial ovarian cancer. J Natl Cancer Inst. 1993;85:653-657. (Pubitemid 23120511)
9. Lampic C, Thurfjell E, Bergh J, Sjoden P-O. Short-and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer. 2001;37:463-469. (Pubitemid 32232110)
10. Swanson V, Dobson H, Power KG, McIntosh IB. The psychological effects of breast screening in terms of patients' perceived health anxieties. Br J Clin Pract. 1996;50:129-135. (Pubitemid 26129565)
11. Grosfeld FJ, Brouwers Smalbraak GJ, et al. Psychosocial consequences of DNA analysis for MEN type 2. Oncology (Huntingt). 1996;10:141-146. (Pubitemid 126550116)
12. Barton MB, Moore S, Polk S, Shtatland E, Elmore JG, Fletcher SW. Increased patient concern after false-positive mammograms: clinician documentation and subsequent ambulatory visits. J Gen Intern Med. 2001;16:150-156. (Pubitemid 34208868)
13. Jatoi I, Zhu K, Shah M, Lawrence W. Psychological distress in U. S. women who have experienced false-positive mammograms. Breast Cancer Res Treat. 2006;100:191-200. (Pubitemid 44631921)
14. Gram IT, Lund E, Slenker SE. Quality of life following a false positive mammogram. Br J Cancer. 1990;62:1018-1022.
15. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999;354:99-105. (Pubitemid 29313143)
16. Henschke CI. Early lung cancer action project: overall design and findings from baseline screening. Cancer. 2000;89:2474-2482.
17. Ellis SM, Husband JE, Armstrong P, Hansell DM. Computed tomography screening for lung cancer: back to basics. Clin Radiol. 2001;56:691-699. (Pubitemid 35023794)
18. Henschke CI, Yip R, Yankeleviz DF, Miettinen OS. Computed tomography screening for lung cancer: Prospects of surviving competing causes of death. Clin Lung Cancer. 2006;7:323-325. (Pubitemid 43950979)
19. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA. 2007;297:953-961. (Pubitemid 46376749)
20. Romano PS, Mark DH. Patient and hospital characteristics related to inhospital mortality after lung cancer resection. Chest. 1992;101:1332-1337.
21. Bach PB, Cramer LD, Schrag D, Downey RJ, Gelfand SE, Begg CB. The influence of hospital volume on survival after resection for lung cancer. N Engl J Med. 2001;345:181-188. (Pubitemid 32662128)
22. Ganti AK, Mulshine JL. Lung cancer screening. Oncologist. 2006;11:481-487. (Pubitemid 43788274)
23. Twombly R. Lung cancer screening debate continues despite international CT study results. J Natl Cancer Inst. 2007;99:190-195.
24. Patz EFJ, Goodman PC, Bepler G. Current concepts: screening for lung cancer. N Engl J Med. 2000;343:1627-1633. (Pubitemid 32162988)
25. Byrne MM, Weissfeld J, Roberts MS. Anxiety, fear of cancer, and perceived risk of cancer following lung cancer screening. Med Decis Making. 2008;28:917-925.
26. Wilson DO, Weissfeld JL, Fuhrman CR, et al. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med. 2008;178:956-961.
27. Ware JE. Scales for measuring general health perceptions. Health Serv Res. 1976;11:396-415.
28. McDowell I, Newell C. Measuring Health: A Guide to Rating Scales and Questionnaires. 2nd ed. New York, NY: Oxford University Press; 1996.
29. Stanley MA, Beck JG, Zebb BJ. Psychometric properties of four anxiety measures in older adults. Behav Res Ther. 1996;34:827-838. (Pubitemid 26364883)
30. Spielberger CD. Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto, CA: Consulting Psychologists Press; 1983.
31. Molenberghs G, Verbeke G. Models for Discrete Longitudinal Data. Springer Series in Statistics. New York: Springer-Verlag; 2005.
32. Pan W. Akaike's information criterion in generalized estimating equations. Biometrics. 2001;57:120-125. (Pubitemid 32200145)
33. Brown H, Presscott R. Applied Mixed Models in Medicine. West Sussex, UK: John Wiley & Sons, Ltd; 1999.
34. Goetzel RZ, Anderson DR, Whitmer RW, Ozminkowski RJ, Dunn RL, Wasserman J. The relationship between modifiable health risks and health care expenditure: an analysis of the multi-employer HERO health risk and cost database. J Occup Environ Med. 1999;40:843-854. (Pubitemid 28493482)
35. Signorini D. Sample size for Poisson regression. Biometrika. 1991;78:446-450.
36. Antill YC, Reynolds J, Young MA, et al. Screening behavior in women at increased familial risk for breast cancer. Fam Cancer. 2006;5:359-368. (Pubitemid 44924112)
37. Paskett ED, White E, Carter WB, Chu J. Improving follow-up after an abnormal Pap smear: a randomized controlled trial. Prev Med. 1990;19:630-641.
38. Melnikow J, Chan BK, Stewart GK. Do follow-up recommendations for abnormal Papanicolaou smears influence patient adherence? Arch Fam Med. 1999;8:510-514.